MKI67 and breast cancer: A study by Spiliotaki explored proliferation in CTCs in serial blood samples from patients with early (≤5 years disease-free) vs. metastatic (>5 years after surgery) breast cancer using Ki67 staining together with Pan-CK and apoptosis marker M30 [47].